BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3245215)

  • 1. Evaluation of surgical results and prediction of prognosis in patients with medullary thyroid carcinoma by analysis of serum calcitonin levels.
    Miyauchi A; Matsuzuka F; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
    World J Surg; 1988 Oct; 12(5):610-5. PubMed ID: 3245215
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of surgical results and prediction of prognosis by analysis of serum tumor marker levels: proposal of a theory tested on patients with medullary thyroid carcinoma].
    Miyauchi A
    Gan No Rinsho; 1988 May; 34(6):739-43. PubMed ID: 3379756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of surgical treatments of medullary thyroid carcinoma by analysis of serum calcitonin levels].
    Miyauchi A; Matsuzuka F; Kuma K; Takai S; Maeda M
    Nihon Geka Gakkai Zasshi; 1987 Jan; 88(1):102-8. PubMed ID: 3821708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcitonin determination as a possibility for the evaluation of surgical result in medullary thyroid carcinoma (C-cell carcinoma)].
    Horn J; Pfarr B; Ziegler R
    Langenbecks Arch Chir; 1975; Suppl():231-4. PubMed ID: 1207235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
    Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
    Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medullary thyroid carcinoma detected by serum calcitonin assay.
    Block MA; Jackson CE; Tashjian AH
    Arch Surg; 1972 Apr; 104(4):579-86. PubMed ID: 5013799
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value of calcitonin determination in the evaluation of completeness of thyroidectomy in medullary carcinoma of the thyroid gland].
    Wasylewski A; Skrzypek J; Kokot F; Sledziński Z
    Endokrynol Pol; 1981; 32(3):239-44. PubMed ID: 7308165
    [No Abstract]   [Full Text] [Related]  

  • 8. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
    Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
    Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin in human serum. Detection by tissue culture bioassay in medullary carcinoma of the thyroid and other disorders.
    Raisz LG; Au WY; Simmons H; Mandelstam P
    Arch Intern Med; 1972 Jun; 129(6):889-93. PubMed ID: 5033285
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analysis of calcitonin level in the diagnosis and evaluation of the results of the treatment of medullary carcinoma of the thyroid gland].
    Krassowski J; Słowińska-Srzednicka J; Gietka M; Sawicki A; Kokot F; Zgliczyński S
    Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):757-9. PubMed ID: 2641802
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma.
    Goltzman D; Potts JT; Ridgway RC; Maloof F
    N Engl J Med; 1974 May; 290(19):1035-9. PubMed ID: 4207025
    [No Abstract]   [Full Text] [Related]  

  • 12. Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma.
    Miyauchi A; Onishi T; Morimoto S; Takai S; Matsuzuka F; Kuma K; Maeda M; Kumahara Y
    Ann Surg; 1984 Apr; 199(4):461-6. PubMed ID: 6712322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endocrinological and clinicopathological studies on medullary thyroid carcinoma. Part 2: Biological behavior of the medullary thyroid carcinoma and its surgical implications (author's transl)].
    Obara T
    Nihon Gan Chiryo Gakkai Shi; 1977 Mar; 12(1):12-23. PubMed ID: 559026
    [No Abstract]   [Full Text] [Related]  

  • 14. The surgery of thyroid cancer.
    Johnston ID
    Br J Surg; 1975 Oct; 62(10):765-8. PubMed ID: 1191935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated calcitonin and procalcitonin levels in nonmedullary benign and malignant thyroid nodules.
    Giovanella L; Maffioli M; Suriano S; Dorizzi RM
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):852-3. PubMed ID: 19863575
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonfamilial medullary thyroid carcinoma.
    Rossi RL; Cady B; Meissner WA; Wool MS; Sedgwick CE; Werber J
    Am J Surg; 1980 Apr; 139(4):554-60. PubMed ID: 7369463
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent results of reoperative surgery in medullary carcinoma of the thyroid.
    Tisell LE; Jansson S
    Wien Klin Wochenschr; 1988 May; 100(11):347-8. PubMed ID: 3407193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma.
    van Heerden JA; Grant CS; Gharib H; Hay ID; Ilstrup DM
    Ann Surg; 1990 Oct; 212(4):395-400; discussion 400-1. PubMed ID: 2222011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin and carcino-embryonic antigen in the follow-up of patients with medullary carcinoma of the thyroid.
    Palmer BV; Harmer CL; Shaw HJ
    Br J Surg; 1984 Feb; 71(2):101-4. PubMed ID: 6692098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D levels and trabecular bone remodelling before and after surgery for medullary thyroid carcinoma.
    Emmertsen K; Melsen F; Mosekilde L; Lund B; Lund B; Sørensen OH; Charles P; Møller J
    Acta Endocrinol (Copenh); 1984 Jul; 106(3):346-9. PubMed ID: 6611007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.